🇺🇸 FDA
Patent

US 11168142

Administration of kynurenine depleting enzymes for tumor therapy

granted A61KA61K35/17A61K38/00

Quick answer

US patent 11168142 (Administration of kynurenine depleting enzymes for tumor therapy) held by The Board of Regents of the University of Texas System expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/17, A61K38/00, A61K39/3955, A61K47/60